We are live on ! Find out more
XENT

Intersect ENT, Inc
XENT

Delisted

XENT was delisted on the 12th of May, 2022.

Back to rankings

0 hedge funds and large institutions have $0 invested in Intersect ENT, Inc in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 126 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 131 → 0 (-131)

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

100% less capital invested

Capital invested by funds: $826M → $0 (-$826M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 126

Holders
–
Holders Change
-131
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
126
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
VI
Versor Investments
New York
-$93.1M
2
BlackRock
BlackRock
New York
-$73.7M
3
MF
Magnetar Financial
Illinois
-$71.1M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$48.7M
5
AAM
Alpine Associates Management
Florida
-$38.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
E
26
Ergoteles
New York
– -$9.34M -333,564 Closed
GF
27
Gabelli Funds
New York
– -$8.62M -307,884 Closed
JP Morgan Chase
28
JP Morgan Chase
New York
– -$8.2M -292,931 Closed
CCM
29
Crabel Capital Management
California
– -$7.66M -273,423 Closed
N
30
Natixis
France
– -$6.85M -244,600 Closed
Norges Bank
31
Norges Bank
Norway
– -$6.81M -243,000 Closed
Charles Schwab
32
Charles Schwab
California
– -$6.79M -242,370 Closed
Qube Research & Technologies (QRT)
33
Qube Research & Technologies (QRT)
United Kingdom
– -$6.48M -231,251 Closed
Calamos Advisors
34
Calamos Advisors
Illinois
– -$6.16M -219,732 Closed
PCM
35
Prelude Capital Management
New York
– -$5.52M -197,047 Closed
State of Wisconsin Investment Board
36
State of Wisconsin Investment Board
Wisconsin
– -$5.47M -195,460 Closed
YCM
37
Yakira Capital Management
Connecticut
– -$4.88M -174,099 Closed
LP
38
LMR Partners
United Kingdom
– -$4.86M -173,473 Closed
CC
39
Carlson Capital
Texas
– -$4.34M -155,000 Closed
GCIA
40
Gabelli & Co Investment Advisers
New York
– -$4.29M -153,299 Closed
HSBC Holdings
41
HSBC Holdings
United Kingdom
– -$4.19M -149,449 Closed
CCM
42
Chicago Capital Management
Illinois
– -$3.95M -141,111 Closed
Citadel Advisors
43
Citadel Advisors
Florida
– -$3.94M -140,474 Closed
OR
44
Olympiad Research
Connecticut
– -$3.53M -125,990 Closed
Marshall Wace
45
Marshall Wace
United Kingdom
– -$3.39M -121,032 Closed
Capstone Investment Advisors
46
Capstone Investment Advisors
New York
– -$3.38M -120,855 Closed
HA
47
Havens Advisors
New York
– -$3.06M -109,097 Closed
Bank of New York Mellon
48
Bank of New York Mellon
New York
– -$3.04M -108,585 Closed
Deutsche Bank
49
Deutsche Bank
Germany
– -$2.99M -106,747 Closed
GLAM
50
Gardner Lewis Asset Management
Pennsylvania
– -$2.88M -102,827 Closed
1
2
3 4 5

XENT Hedge Fund Activity: Q2 2022 in Review

0 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q2 2022, worth a combined $0 — down 100% from $826M a quarter earlier.

Sellers outnumbered buyers: 126 funds closed out of XENT and 0 opened new positions — a net loss of 126 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Versor Investments, exiting entirely with an estimated $93.1M sold.

  • 0 institutional investors held Intersect ENT, Inc (XENT) as of Q2 2022, down from 131 in Q1 2022.
  • Funds reported $0 of Intersect ENT, Inc stock for Q2 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Intersect ENT, Inc positions in Q2 2022 and 126 closed out, a net change of -126 holders.
  • The largest Intersect ENT, Inc seller in Q2 2022 was Versor Investments, an estimated $93.1M sold.

Based on aggregated 13F filings for Q2 2022.